OSRHW
OSR Health, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
- Short sellersSTEADY
Short interest 0.0% to 914 shares. 1.1 days to cover, ≈0.0% of shares.
- TrendDOWNTREND
31% below its 37-day average. New closing low $0.010000 on Oct 23.
Who's buying
13F· Q1 2026| Fund | Move | Value |
|---|---|---|
| TORONTO DOMINION BANK | ADD | $33.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026SecBot reports
3 filings · 0 bullish · 0 bearish · 1 mixed · 2 neutral- NEUTRAL 8-KJun 2, 2026
OSR Holdings entered into an Asset Purchase Agreement with its indirect subsidiary Vaximm AG to…
This is a related-party IP reorganization with no immediate cash impact. The $30 million deferred payment obligation is contingent on clinical success (Phase 2 completion), which is years away and…
- MIXED 8-KApr 30, 2026
OSR Holdings entered into a global exclusive license agreement with its largest shareholder, BCM…
The license deal provides a development pathway but no immediate capital infusion. Monitor for execution of the $30M IP purchase and any progress toward an Ultimate License Agreement or clinical…
- NEUTRAL 8-KApr 9, 2026
OSR Holdings issued a $1.06M senior secured convertible note to White Lion Capital, funded by…
The transaction removes a significant warrant overhang, which could support the stock price in the short term. However, the new debt increases leverage, and the eventual conversion will dilute…
All OSRHW filing & press-release reports (3)
- 8-K reportJun 2, 2026
- 8-K reportApr 30, 2026
- 8-K reportApr 9, 2026